Immunotherapy (Issue 4) | Special Reports

Right Patient for Immunotherapy in NSCLC Explored

November 26, 2014

Clinical Articles

Multiple trials are ongoing in NSCLC with immunotherapy agents. As with most cancers, however, there is also a need to identify which types of patients with NSCLC might benefit the most from these new therapies.

Weight May Affect Toxicity of Immunotherapies

November 26, 2014

Clinical Articles

Immunotherapy is the only alternative to chemotherapy and radiation for the treatment of advanced-stage tumors and recent research has shown a correlation between weight and the toxicity of these immunotherapies.

Immunotherapy Potential Option in Mesothelioma Treatment

November 26, 2014

Clinical Articles

In malignancies with limited response rates to existing radiation and/or chemotherapy, immunotherapy is being investigated as a potential adjunct, with promising results, particularly in the treatment of malignant mesothelioma.